Objective: To review recent advances in the field of endothelial cell heterogeneity, and to apply this knowledge to an understanding of site-specific vasculopathy, including acute lung injury. Data Sources and Study Selection: Published research and review articles in the English language related to endothelial cell biology and endothelial cell heterogeneity. Data Extraction and Synthesis: The results of published studies have been used to provide a perspective of endothelial cell phenotypes in health and disease. Conclusions: The structure and function of endothelial cells are differentially regulated in space and time. Far from being a giant monopoly of homogeneous cells, the endothelium repre-sents a consortium of smaller enterprises of cells located within blood vessels of different tissues. Although united in certain functions, each enterprise is uniquely adapted to meet the demands of the underlying tissue. The endothelium may also vary in its response to pathophysiologic stimuli and therefore contribute to the focal nature of vasculopathic disease states. In acute lung injury, the unique properties of the endothelium may conspire with systemic imbalances to localize pathology to the pulmonary vasculature. (Crit Care Med 2003; 31[Suppl.]:S221-S230) KEY WORDS: endothelium; endothelial cells; heterogeneity; vascular bed S221 Crit Care Med 2003 Vol. 31, No. 4 (Suppl.) a The species and the choice of assay (protein, mRNA) vary between studies.
V ascular diseases are among the most common causes of morbidity and mortality in the Western world. A remarkable feature of these disorders is the focal nature of their distribution. For example, diabetes is associated with vasculopathy in the small arterioles of the retina and kidney (1); veno-occlusive disease, a common complication of myeloablative therapy, affects the sinusoids of the liver (2); hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura are characterized by pathology in every microvascular bed with the notable exception of the liver and the lungs (3, 4) ; the congenital hypercoagulable states exemplified by factor V Leiden predispose patients to an increased risk of venous, but not arterial, thrombosis (5, 6); and in acute lung injury (ALI), pathology in the small and large vessels of the lung may occur in the absence of similar lesions in other organ systems. In fact, there does not exist a single disease that affects virtually every blood vessel type in the body.
An important goal in vascular biology is to define the mechanisms of site-specific pathology. The endothelium has a key role in dictating these disease patterns. It is widely appreciated that endothelial cells function in a multitude of physiologic processes including: the control of cellular trafficking, the regulation of vasomotor tone, the maintenance of blood fluidity, and the growth of new blood vessels. However, it is less well recognized that endothelial cell phenotypes are differentially regulated in space and time (Table 1) . At a single point in time, structural and functional phenotypes vary between segments of the vascular tree. At any given location, the endothelial cell phenotypes may change from one moment to the next. Endothelial cell heterogeneity occurs between different organs, within the vascular loop of a given organ, and even between neighboring endothelial cells of a single blood vessel. The aims of this review are to underscore the scope of endothelial cell heterogeneity, to discuss the underlying mechanisms of vascular diversity, and to apply these principles to an understanding of ALI.
Mapping of Endothelial Cell Heterogeneity
Heterogeneity in Structure. From a structural perspective, endothelial cells from different sites of the vascular tree differ in size, shape, thickness, and nuclear orientation. For example, endothelial cells that line the pulmonary artery of the rat are larger and more rectangular than those lining the aorta (7), whereas endothelial cells in the aorta are thicker than their counterparts in capillaries or veins (8) . En face preparations of rabbit blood vessels demonstrate that endothelial cells are larger in the inferior vena cava (average length 108 m; average width 14 m) compared with the aorta (average length 96 m; average width 11 m) (9). The nuclei of most aortic endothelial cells are positioned downstream from the midpoint of the longitudinal axis of the cell; in the inferior vena cava, most nuclei are positioned upstream from this point (9). Additionally, endothelial nuclei in the aorta are oriented parallel to the axis of blood flow and become realigned with the new direction of flow, when the blood vessels are surgically repositioned (10). The relationship between nuclear orientation and direction of blood flow has been reproduced using in vitro model systems of fluid shear stress (11).
Microvilli have been reported to be most numerous at sites of major flow disturbances in the larger veins of rabbits (12). Thin filaments are found more frequently in arterioles and venules compared with capillaries (13, 14). In a systematic study of the mouse diaphragm vasculature, arteriolar endothelium was shown to contain fewer plasmalemmal vesicles compared with the capillaries or postcapillary venules (15). The nature of the endothelial cell junction varies between different segments of the vascular tree: arterioles have a continuous network of tight junctions that surround large communicating (gap) junctions, arteries have a less complex composite system of tight and communicating junctions, capillaries have no communicating junctions, and venules have the least organized endothelial junctions (16 -18). In frogs, the cytoplasmic volume density of Weibel-Palade bodies is reported to correlate inversely with the distance from the heart, with highest levels (8% cytoplasmic volume) in the thoracic aorta and lowest levels in capillaries (0.3%) (19) .
Heterogeneity in Expression Patterns. Endothelial cells are heterogeneous with respect to their cell surface glycoproteins and lectin binding patterns (20 -24), protein expression, and mRNA expression ( Table 2 ) (20 -24). With few exceptions, virtually all endothelial cell-specific genes are differentially or unevenly expressed throughout the vascular tree.
Recent studies have demonstrated differences in transcription factor expression between subsets of endothelial cells and vascular beds (25-27). For example, en face preparations of the mouse aorta have revealed basal and lipopolysaccharide-induced expression of nuclear factor-B in a subpopulation of endothelial cells that reside in regions with high probability for atherosclerotic lesion development (25) . In mouse tissues, the early growth response gene-1 transcription factor has been localized to occasional endothelial cells of the heart and brain (27). Early immediate transcription factors such as nuclear factor-B and early growth response gene-1 transduce signals from the extracellular environment and regulate the expression of multiple downstream target genes. Thus, even small differences in expression between endothelial cells may account for large differences in environmentally induced gene programs.
Intracellular signaling pathways may also differ between subsets of endothelial cells in vivo. Recent studies have uncovered novel vascular endothelial growth factor (VEGF)-like molecules that are specific to certain organ types. An endocrine gland-derived VEGF (termed EG-VEGF) has been identified as a mitogen that is specific for the endothelium of steroidogenic glands (28). Although EG-VEGF does not demonstrate structural homology to the VEGF family, it is functionally similar; it is up-regulated by hypoxia and induces endothelial cell migration, proliferation, and fenestration (28). Dot blot analyses of tissue RNA arrays have demonstrated that EG-VEGF mRNA is limited to steroidogenic endocrine glands. However, the biological effects of EG-VEGF, under both in vitro and in vivo conditions, were limited to the endothelium from steroidogenic glands, suggesting that the organ-specific effects of EG-VEGF are determined not only by the availability of the growth factor but also the capacity of the endothelial cell to respond to the signal.
Recent evidence suggests that fibroblast growth factor (FGF) signaling is regulated by vascular bed-specific mechanisms (29). FGF signaling involves the formation of macromolecular complexes between FGF, FGF protein tyrosine kinase receptors, and heparan sulfate pro- Low in brain (152) teoglycans. In late-stage mouse embryos, FGF-2 binds to all vascular beds examined, whereas FGF-4 only binds to brain capillaries. Because FGF-2 and FGF-4 are known to recognize the same FGF receptor, the limited binding of FGF-4 to the vascular endothelium of the brain may be explained by site-specific differences in heparin sulfate synthesis and sulfation patterns (29). Based on the above data, it seems likely that other site-specific signaling networks exist and that they contribute in a critical way to the generation and/or maintenance of endothelial cell heterogeneity.
Heterogeneity in Function. The principle functions of the endothelium-the control of hemostasis, vasomotor tone, cell and nutrient trafficking, barrier function, and angiogenesis-are differentially regulated between different sites of the vascular tree and from one moment in time to the next (5, 6, 30, 31).
Several studies point to site-specific regulation of vasomotor tone. For example, shear stress induces greater nitric oxide-dependent dilation of porcine epicardial arterioles compared with venules (32). In the mouse, expression of endothelial nitric oxide synthase protein and mRNA is highest in the heart and lung, and lowest in the liver (33). In individual organs, endothelial nitric oxide synthase expression is higher on the arterial side of circulation (34, 35) . In rat models of increased blood flow, endothelial nitric oxide synthase levels are induced in the aorta, but not in pulmonary arteries (36, 37) . In a rat model of hypoxia, prostacyclin production is higher in the pulmonary artery compared with the aorta (38). Endothelial ␣2-receptors are expressed in conduit arteries, but not at the arteriolar level (32). A final example of vascular bed-specific control of vasomotor tone can be seen in the hamster cheek pouch-differences in acetylcholineinduced nitric oxide activity and angiotensin conversion exist in distinct segments of serial-arranged arterioles (39, 40).
Normally, the intact endothelium expresses undetectable or low levels of Eselectin and vascular cell adhesion molecule-1. In contrast, P-selectin and intercellular adhesion molecule-1 are basally expressed in the endothelium, with levels that vary between different vascular beds and different segments of the vascular loop (41-43). Moreover, endothelial cell activation results in stimulus-and organ-specific induction of the various adhesion molecules (42-45).
Under resting conditions, the distribution of hemostatic factors in the intact endothelium varies between vascular beds. In whole organ extracts from mice, endothelial tissue plasminogen activator mRNA expression is highest in the heart and brain, urokinase plasminogen activator expression is highest in the kidney, and plasminogen activator inhibitor-1 expression is highest in the aorta (46). Tissue factor pathway inhibitor is most abundant in the microvascular endothelium (47), and thrombomodulin is expressed in all vascular beds with the exception of the brain (48). As with the adhesion molecules, stimulation of the intact endothelium results in vascular bed-specific changes in hemostatic properties (46). The most compelling evidence that the hemostatic balance is regulated by organ-specific mechanisms is derived from studies of knock-out animals, in which the deletion of a natural anticoagulant results in site-specific differences in fibrin deposition (6, 49).
Assays for Cataloguing Endothelial Cell Heterogeneity. A wide range of assays has been used to uncover and map endothelial cell heterogeneity (Table 3) . Scanning electron microscopy has provided some of the earliest and most compelling descriptions of phenotypic diversity among endothelial cells (50 -52). Immunohistochemistry and in situ hybridization studies have been used to map the expression of a protein or mRNA species to unique sites of the vascular tree (see Table 2 for references). Whole tissue extracts or purified endothelial cells have been used to generate antibodies that recognize site-specific epitopes in the vasculature (53) (54) (55) (56) (57) (58) . The injection of labeled antibodies into mice has provided a unique perspective of vascular heterogeneity at the level of cell adhesion molecule expression (42, 43, 59) . More recently, innovative proteomic and genomic approaches have been applied to the study of vascular diversity. For example, antibody and subfractionated protocols have been used to generate monoclonal antibodies that specifically target the caveolae in the microcirculation of the lung (60) . Other groups of cells have used phage-display peptide libraries to select for peptides that home to specific vascular beds in vivo (61) (62) (63) . In a follow-up study, affinity chromatography was used to isolate a 55-kDa receptor that selectively binds to one of the lung-selective peptides (64) . Based on protein sequencing, the receptor has been identified as membrane dipeptidase, a cell surface zinc metalloprotease that is involved in the metabolism of glutathione and leukotriene D4 (64) . Although there are technical challenges in studying transcriptional profiles in the context of an appropriate microenvironment, DNA microarrays have recently been used to map cell subtype-specific gene expression in different populations of endothelial cells (65) (66) (67) . One approach that holds promise is the combined use of laser capture microdissection and transcriptional profiling to analyze gene expression in the intact endothelium.
Mechanisms of Endothelial Cell Heterogeneity
Endothelial cell heterogeneity may arise from factors that are inherent in the cell or from signals residing in the extracellular environment. The genetic (intrinsic) hypothesis predicts that organspecific phenotypes are predetermined before they migrate from the mesoderm to specific vascular beds. Support for this model is largely derived from fate mapping studies in vertebrate embryos, showing that endothelial cell precursors, or angioblasts, are capable of differentiating along several genetically preprogrammed lines.
The environmental (extrinsic) hypothesis maintains that site-specific properties of endothelial cells are governed by local microenvironmental cues present within the resident tissue. Indeed, there is a growing appreciation for the importance of the local environment in determining endothelial cell phenotypes; the interaction between the microenvironment and the endothelial cell may involve soluble mediators, cell-cell communication, and the synthesis and organization of matrix proteins. It is very likely that phenotypic heterogeneity of the endothelium is determined by a combination of genetic and environmental factors.
Genetic Predeterminants of Endothelial Cell Heterogeneity. Retroviral cell lineage studies in the chick embryo have uncovered distinct embryonic origins for coronary endothelium and the endocardium (68, 69) . The endocardial endothelium is believed to derive from lateral mesoderm, whereas the coronary endothelium originates from the proepicardial organ located in the dorsal mesocardium. Interestingly, these progenitor cells are multipotent; they give rise to endothelial cells, vascular smooth muscle cells, and fibroblasts of the coronary vessel. The genetic programs that underlie the sitespecific formation of blood vessels within the heart have yet to be elucidated.
One of the most important events that occurs during vascular development is the specification of endothelial tubes as arteries or veins. Until recently, it was widely believed that the phenotypic differences between arterial and venous endothelial cells were attributable to environmental factors, e.g., differences in hemodynamic forces, direction of blood flow, oxygen levels, subendothelial matrix, and interactions with neighboring smooth muscle cells. This view has been challenged by the recent discovery of certain molecules that are specifically expressed in arterial or venous endothelial cells during early development before the onset of circulation. These molecules in-clude members of the ephrin, notch, gridlock, and Bmx families (70 -78) .
A number of other gene products are expressed predominantly on the arterial side of the circulation during development and/or during adult life, including the transcription factors Sox-13 (79), endothelial per-arylhydrocarbon receptornuclear translocator-Sim domain protein-1 (EPAS-1) (80), and hairy-related transcription factor 1-3 (81) , and the transmembrane receptor protein tyrosine phosphatase- (82) . The degree to which these properties are genetically predetermined and whether or not they have an active role in mediating arterial fate are yet to be determined.
Several investigations point to the existence of arterial and venous differences in VEGF signaling. For example, in chicken embryos, neuropilin-1-an isoform-specific VEGF receptor able to bind the heparin-binding VEGF isoforms (83)-is expressed predominantly on the venous side of the circulation. However, neuropilin-2-a splice-form-specific VEGF receptor-is expressed on the arterial side of the circulation in a pattern that is analogous to that of ephrinB2 (84) .
It has been hypothesized that endothelial cells and hematopoietic cells arise from a common progenitor cell called the hemangioblast (85, 86) . However, the identity of this cell remains elusive at present (87) . Recent studies suggest that endothelial cell progenitors may persist in adult life. Indeed, there is evidence that endothelial precursors reside in the bone marrow, circulate freely in the blood, maintain the capacity to proliferate, and contribute to the formation of new blood vessels (88 -91) . Circulating differentiated endothelial cells have low proliferative capacity and do not participate in neovascularization, making it possible to distinguish them from the circulating endothelial precursor cells (92, 93) . The role that circulating endothelial precursor cells have in physiologic or pathophysiologic angiogenesis is yet to be established. Moreover, it is unclear whether bone marrow-derived progenitors represent a single clone or whether they carry different genetic programs and information for unique endothelial cell phenotypes.
Environmental Determinants of Endothelial Cell Heterogeneity. Despite the evidence for genetic predetermination in mediating some aspects of endothelial cell heterogeneity, most phenotypic dif-ferences in the endothelium-at least at the level of the postnatal microcirculation-are governed by the extracellular milieu.
Organ-Specific Differentiation of Endothelial Cells Is Inducible by Coculture, Components of the Extracellular Matrix, or Soluble Mediators. The importance of the microenvironment is demonstrated when endothelial cells are cultured in vitro; they are uncoupled from critical extracellular cues-including cell-cell communication, paracrine and endocrine signals, oxygenation, and flow-and undergo phenotypic drift. Site-specific properties of the endothelium may be reinduced by coculturing endothelial cells with organ-derived extracellular matrix or nonendothelial cell types. For example, aortic endothelial cells express lung endothelial cell adhesion molecule-1 when cultured in the presence of lung extracellular matrix (94) . Cultured bovine adrenal cortex endothelial cells are induced to form fenestrae when cultured on a Madin-Darby canine kidney cellderived matrix (95) . Mouse brain capillary endothelial cells express P-glycoprotein when cultured with brain matrix, but not with matrix derived from the lung, liver, or kidney (96) . The loss of bloodbrain barrier phenotype in cultured endothelial cells is partially reversed by coculture with astrocytes (97) (98) (99) . Similarly, the coculture of mouse cardiac microvascular endothelial cells with cardiomyocytes restores, in part, the properties of the intact endothelium (100) .
Endothelial cells that are derived from different vascular beds may exhibit distinct phenotypes in vitro . Although these observations are consistent with a role for lineage predetermination, there are important caveats. First, the extent to which these differences reflect site-specific properties in vivo is not always clear. Second, certain phenotypes that are acquired in vivo through the interaction of the endothelial cell with the local environment may be "locked in" or irreversible. Indeed, there is no reason to believe that all environmentally induced properties of the endothelial cell retain plasticity in vitro.
As a final example of the importance of the microenvironment in modulating phenotypes, the exposure of endothelial cells to any number of extracellular mediators (including inflammatory cytokines, chemokines, growth factors, and endotoxin) and alterations in oxygenation and hemodynamic forces may have pro-found effects on endothelial cell structure, gene expression, and function.
Transplantation Studies. The role of the microenvironment in mediating vascular bed-specific phenotypes is also implicated in transplantation studies. For example, when purified astrocytes are transplanted into the anterior chamber of the eye and to the chick chorioallantoic membrane, the neovessel associated with the grafts becomes impermeable to Evan's blue dye, suggesting that the endothelium acquires barrier features (99) . In transgenic mice, endothelial cells from the vasculature of the ear were shown to acquire cardiac microvascular bedspecific properties when exposed to the environment of the heart (100) .
Endothelial Cell-Specific Genes Are Regulated by a Modular Mechanism. In standard transgenic mouse assays, every endothelial cell-specific promoter tested to date, with the possible exception of a long fragment from the Tie-2 gene, has been shown to direct expression in distinct subsets of endothelial cells in the adult vasculature (33, 100, [122] [123] [124] [125] [126] [127] [128] [129] [130] . Moreover, when integrated as single copies into a defined locus of the mouse genome, different promoter fragments either from different endothelial cellspecific genes or from the same gene, contain information for vascular bedspecific gene expression (131) (132) (133) . Together, these data provide strong evidence that endothelial cell-specific genes are regulated in a modular manner. According to this model, the expression of a single gene within the endothelium is not regulated by a common transcriptional control mechanism, but by a constellation of site-specific signaling pathways (30).
Application of Principles of Endothelial Cell Heterogeneity to the Understanding of ALI
Lung Endothelium in Health. There are many examples of site-specific properties of lung endothelium. Structural differences exist not only between the endothelium of pulmonary and nonpulmonary vasculature (e.g., pulmonary artery vs. aorta), but also between different blood vessel types in the lung. For example, within the extra-alveolar pulmonary microcirculation of the rat lung, the mean thickness of the endothelium in muscular vessels is greater than that of partially muscular or nonmuscular microvessels (50). Vesicle densities are greater in alveolar capillary endothelium compared with endothelial cells from extra-alveolar microvessels (50). Scanning electron microscopy studies of the pulmonary artery reveal a meshwork of irregular projections or microvilli, which increase the surface area of the alveolar endothelial cells (51). These structural differences are likely to be coupled to regional heterogeneity in function, and to reflect the unique demands of the local microenvironment.
As with all vascular beds, endothelial cells in the lung express a unique repertoire of genes and gene products, some of which are included in Table 2 . In en face preparations of rat vessels, the aorta and femoral artery express detectable levels of angiotensin II, whereas the pulmonary artery does not (134) . Compared with vascular beds from other organs, the endothelium of the lung expresses several site-specific proteins, including the dermatan sulfate, endothelial-specific molecule-1 (135) , and the chloride channel, lung-endothelial cell adhesion molecule-1 (136) . Heterogeneity also exists when comparing different segments of the vascular loop within the lung. For example, tissue factor pathway inhibitor is expressed predominantly in the microvessels, endothelial nitric oxide synthase in the arteries, and von Willebrand factor in the veins (30). In mice and primates, tissue-type plasminogen activator is expressed in endothelial cells of the bronchial, but not the pulmonary circulation (137) .
Intact lung venular capillaries contain a subclass of endothelial cells called pacemaker cells, which generate calcium ion (Ca 2ϩ ) oscillations that spread to adjacent endothelial cells (138) . The intercommunication between the pacemaker cells and neighboring endothelial cells has an important role in coordinating spatial and temporal signaling in the lung vasculature (138) .
From a mechanistic standpoint, there is increasing evidence to suggest that endothelial cells from micro-and macrovascular segments of the lung are derived from different origins during embryogenesis (139 -141) . For example, microvascular endothelium in the lung is derived from blood islands by a process that involves vasculogenesis; macrovascular endothelial cells originate from the pulmonary truncus by angiogenesis. Although these genetic programs may be important in specifying microvascular and macrovascular fates, terminal differentiation is likely to be critically dependent on microenvironmental cues.
Lung Endothelium in ALI. How can we use the principles of endothelial cell heterogeneity to explain the focal nature of ALI? Simply put, if the structure and function of lung endothelial cells differ from other organs, it follows that the response of the endothelium to a systemic stimulus such as sepsis will also differ between organs. In approaching the pathophysiology of ALI, it is important to consider the multiple and complex interactions between the lung and other organ systems (Fig. 1) .
ALI is usually initiated by a local (e.g., pneumonia) or systemic (e.g., sepsis or multiple trauma) insult, and may arise from a single hit or from multiple hits. Regardless of its origin or nature, the insult has the potential to perturb the organism in ways that differ from one organ to the next. A compelling example of the organ-specific nature of the host response is derived from transcriptional profiling experiments. In a rat model of cecal ligation and puncture, sepsis triggered the activation and repression of multiple genes, with each organ displaying a distinctive molecular response (142) . These observations are important for several reasons. First, some of the reported changes may reflect altered gene expression in the underlying endothelium. Second, organ-specific changes in the expression of autocrine factors (endothelial cells) or paracrine factors (nonendothelial cells) may have profound effects on the response of the local endothelium. A final point to consider is that altered function in one organ may have a large downstream effect on other organs. For example, the finding that tumor necrosis factor-␣ levels are increased in the lung raises the possibility that the lungderived cytokine activates endothelial cells in distant vascular beds.
In keeping with the theme of endothe-lial cell heterogeneity, each vascular bed internalizes, integrates, and responds to the systemic changes in its own unique way. This is important because the endothelium, as a "gatekeeper" between the blood and underlying tissue, is the final arbiter of leukocyte trafficking, hemostatic balance, and vasomotor tone. Indeed, previous studies have shown that sepsis induces site-specific changes in lung endothelium. For example, the systemic administration of lipopolysaccharide to mice results in a down-regulation of von Willebrand factor mRNA expression in the lung, compared with an upregulation in the heart and kidney (143) .
Moreover, lipopolysaccharide-mediated induction of E-selectin protein is greater in the lung compared with other organs (42). In a cecal ligation and perforation model in mice, P-selectin, but not Eselectin protein is increased in the lung, an effect that was independent of lipopolysaccharide (44). In a hyperoxia model of lung inflammation, tissue-type plasminogen activator is newly expressed in pulmonary arterioles having a diameter between 7 and 20 M (137). In humans, inflammation of the lung has been associated with new expression of granulocyte-macrophage colony-stimulating factor in the microvascular endothelium (117) .
In ALI, the unique properties of the lung endothelium help to channel the systemic changes into local pathology. Although the precise sequence of events remains elusive and is likely to vary between clinical syndromes and individual patients, the process includes some combination of: activation of the coagulation and inflammatory cascades, increased leukocyte rolling, adhesion, and transmigration, fibrin deposition, and disruption of the epithelial and/or endothelial barrier.
Once activated, these pathways initiate and engage in cycles that feedback and amplify the process. The nonlinear nature of these networks poses tremendous challenges from a therapeutic standpoint (31).
Important goals for the future are to elucidate which properties of the lung endothelium interact with systemic insults such as sepsis to induce local phenotypes, to determine which of these properties and/or local phenotypes are critical determinants of morbidity and mortality, and to evaluate the potential for reversing or attenuating one or another of these processes for therapeutic gain. Figure 1 . The lung endothelium placed in context. In evaluating the role of site-specific endothelial cell properties in mediating acute lung injury (ALI), it is helpful to consider the following: 1) under normal conditions, endothelial cell phenotypes (and subsequent vulnerability to pathophysiologic stimuli) differ both between organs and within a given organ; 2) in clinical conditions associated with ALI, the pulmonary endothelium is exposed to shifts in the microenvironment, both from the luminal and abluminal side. Inflowing blood may contain altered concentration and/or activity of cytokines, growth factors, hormones, glucose, acid/base-electrolytes, lipopolysaccharide (LPS), or other pathogen-associated properties. Moreover, the blood may be hypoxic, hyper-or hypothermic, and delivered under lower than normal perfusion pressures. Many of these properties are modulated by the health of other organ systems, including the liver, kidney, and the brain. On the abluminal side, the endothelium may be exposed to ventilator-associated forces and/or changes in the properties of inhaled air; 3) the local endothelial cell phenotypes conspire with the changes in systemic input (blood and air) to induce local pathophysiology; 4) once activated, these site-specific pathways may engage in vicious autocrine and paracrine loops, serving to accentuate the process. 
